Emergent BioSolutions | EBS - 资产

股票价格
8.29
每天变化
-0.15 -1.78%
每月一次
-24.84%
每年
43.67%
Q1 预测
8.19


金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 432.8M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


资产 更改 日
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Akebia Therapeutics USD 376.56M 12.41M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amarin USD 659.81M 10.31M 2025-09
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Coherus Biosciences USD 516.52M 77.05M 2025-09
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Exact Sciences USD 5.86B 39.38M 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Heron Therapeutics USD 248.95M 16.86M 2025-09
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Lexicon Pharmaceuticals USD 225.58M 72.09M 2025-06
Lonza CHF 19.73B 1.85B 2024-12
Merck USD 129.55B 12.02B 2025-09
Moderna USD 12.34B 203M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
United Therapeutics USD 7.88B 528.9M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Xoma USD 263.15M 39.7M 2025-09